» Articles » PMID: 28590090

Motile Hepatocellular Carcinoma Cells Preferentially Secret Sugar Metabolism Regulatory Proteins Via Exosomes

Overview
Journal Proteomics
Date 2017 Jun 8
PMID 28590090
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are deliverers of critically functional proteins, capable of transforming target cells in numerous cancers, including hepatocellular carcinoma (HCC). We hypothesize that the motility of HCC cells can be featured by comparative proteome of exosomes. Hence, we performed the super-SILAC-based MS analysis on the exosomes secreted by three human HCC cell lines, including the non-motile Hep3B cell, and the motile 97H and LM3 cells. More than 1400 exosomal proteins were confidently quantified in each MS analysis with highly biological reproducibility. We justified that 469 and 443 exosomal proteins represented differentially expressed proteins (DEPs) in the 97H/Hep3B and LM3/Hep3B comparisons, respectively. These DEPs focused on sugar metabolism-centric canonical pathways per ingenuity pathway analysis, which was consistent with the gene ontology analysis on biological process enrichment. These pathways included glycolysis I, gluconeogenesis I and pentose phosphate pathways; and the DEPs enriched in these pathways could form a tightly connected network. By analyzing the relative abundance of proteins and translating mRNAs, we found significantly positive correlation between exosomes and cells. The involved exosomal proteins were again focusing on sugar metabolism. In conclusion, motile HCC cells tend to preferentially export more sugar metabolism-associated proteins via exosomes that differentiate them from non-motile HCC cells.

Citing Articles

Extracellular vesicles in tumor immunity: mechanisms and novel insights.

Kuang L, Wu L, Li Y Mol Cancer. 2025; 24(1):45.

PMID: 39953480 PMC: 11829561. DOI: 10.1186/s12943-025-02233-w.


Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation.

Beaumont J, Barbeau L, Ju J, Savelkouls K, Bouwman F, Zonneveld M J Extracell Vesicles. 2024; 13(7):e12449.

PMID: 39001708 PMC: 11245686. DOI: 10.1002/jev2.12449.


Extracellular vesicles and particles as mediators of long-range communication in cancer: connecting biological function to clinical applications.

Asao T, Tobias G, Lucotti S, Jones D, Matei I, Lyden D Extracell Vesicles Circ Nucl Acids. 2024; 4(3):461-485.

PMID: 38707985 PMC: 11067132. DOI: 10.20517/evcna.2023.37.


Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology.

Asleh K, Dery V, Taylor C, Davey M, Djeungoue-Petga M, Ouellette R Biomark Res. 2023; 11(1):99.

PMID: 37978566 PMC: 10655470. DOI: 10.1186/s40364-023-00540-2.


Emerging diversity in extracellular vesicles and their roles in cancer.

Sohal I, Kasinski A Front Oncol. 2023; 13:1167717.

PMID: 37397375 PMC: 10312242. DOI: 10.3389/fonc.2023.1167717.